Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+9.1%
5Y CAGR+3.1%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+9.1%/yr
vs +14.4%/yr prior
5Y CAGR
+3.1%/yr
Recent acceleration
Acceleration
-5.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$67.67M+16.9%
2024$57.88M+59.6%
2023$36.27M-30.4%
2022$52.12M+57.7%
2021$33.05M-43.0%
2020$57.99M+34.5%
2019$43.10M+41.6%
2018$30.43M+16.5%
2017$26.12M+58.5%
2016$16.48M-